As Annual Recurring Revenue Accelerates, CrowdStrike Buy?
CrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
Read about user experiences with no fee travel points cards. Gain insights to enhance your travel rewards journey!
17,260 articlesCrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
U.S. stocks pulled back after signals that a ceasefire may be unraveling, lifting oil and turning traders toward safe...
loanDepot is re-entering the wholesale market after a four-year pause, launching a new leadership team and a platform...
Two flagship crypto ETFs from BlackRock pit Ethereum’s usage thesis against Bitcoin’s scarcity thesis. Here’s how IBI...
Ford reveals a heavy Q4 loss tied to Model e impairments, renewing Reddit-driven skepticism about its EV turnaround a...
On a volatile trading day, fuelcell energy stock tumbling becomes a talking point for traders and long-term holders a...
Grove Collaborative, trading as GROV, is navigating a challenging yet hopeful path. This article breaks down grove co...
A high-profile fund manager dumped a huge chunk of AMD stock in one day. The move sparked questions about portfolio s...
Deciding how to own the S&P 500 can feel overwhelming. This guide breaks down the pros and cons of RSP versus VOO, sh...
Gauntlet, a veteran analytics provider in the DeFi space, secured $125 million from SBI Holdings in June, signaling g...
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Rising defense budgets are reshaping the investing landscape. This guide explains why two big players may benefit and...